November 2024

An ACCP speaker explains that the FDA faces a multitude of challenges.

The agency outlines key elements for building effective hospital sepsis programs.

The workshop addressed trends, initiatives, and regulations for quality compounding.

PBM reforms and regulatory changes have reshaped the industry landscape.

Pharmacists can bridge gaps through education, inclusive care, and streamlined access.

This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.

These therapies represent an encouraging advancement in cardiovascular care.

Pharmacogenomic testing can help identify patients' genetic profiles, revealing why certain drugs may be less effective or cause adverse effects.